104 related articles for article (PubMed ID: 17602726)
1. A new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model.
Aletti GD; Santillan A; Eisenhauer EL; Hu J; Aletti G; Podratz KC; Bristow RE; Chi DS; Cliby WA
Gynecol Oncol; 2007 Oct; 107(1):99-106. PubMed ID: 17602726
[TBL] [Abstract][Full Text] [Related]
2. Risk stratification and outcomes of women undergoing surgery for ovarian cancer.
Patankar S; Burke WM; Hou JY; Tergas AI; Huang Y; Ananth CV; Neugut AI; Hershman DL; Wright JD
Gynecol Oncol; 2015 Jul; 138(1):62-9. PubMed ID: 25976399
[TBL] [Abstract][Full Text] [Related]
3. At the Edge of a New Frontier in Quality Measures.
Kougias P; Sharath SE
JAMA Surg; 2024 Mar; 159(3):322. PubMed ID: 38150236
[No Abstract] [Full Text] [Related]
4. The Influence of Surgical Complexity and Center Experience on Postoperative Morbidity After Minimally Invasive Surgery in Gynecologic Oncology: Lessons Learned from the ROBOGYN-1004 Trial.
Lambaudie E; Bogart E; Le Deley MC; El Hajj H; Gauthier T; Hebert T; Collinet P; Classe JM; Lecuru F; Motton S; Conri V; Ferrer C; Marchal F; Ferron G; Probst A; Jauffret C; Narducci F
Ann Surg Oncol; 2024 Jul; 31(7):4566-4575. PubMed ID: 38616209
[TBL] [Abstract][Full Text] [Related]
5. Prerequisites to improve surgical cytoreduction in FIGO stage III/IV epithelial ovarian cancer and subsequent clinical ramifications.
de Jong D; Thangavelu A; Broadhead T; Chen I; Burke D; Hutson R; Johnson R; Kaufmann A; Lodge P; Nugent D; Quyn A; Theophilou G; Laios A
J Ovarian Res; 2023 Nov; 16(1):214. PubMed ID: 37951927
[TBL] [Abstract][Full Text] [Related]
6. Visceral obesity determined by CT as a predictor of short-term postoperative complications in patients with ovarian cancer.
Nie X; Zhang L; Meng H; Zhong Y; Jiang Y; Chen T; Cheng W
Arch Gynecol Obstet; 2024 Apr; 309(4):1491-1498. PubMed ID: 37698603
[TBL] [Abstract][Full Text] [Related]
7. The NEWS2 score predicts prolonged hospitalization in the intensive care unit in major surgery patients.
Karabacak P; Bindal A; Turan İ; Erdemoglu E; Ceylan BG
Turk J Obstet Gynecol; 2023 Sep; 20(3):179-183. PubMed ID: 37667477
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with emergency room readmission after elective surgery for ovarian carcinoma.
Salcedo-Hernandez RA; Barquet-Muñoz S; Isla-Ortiz D; Lucero-Serrano F; Lino-Silva LS; de León DC; Cetina-Perez L
BMC Womens Health; 2023 Sep; 23(1):473. PubMed ID: 37667261
[TBL] [Abstract][Full Text] [Related]
9. Change of Fagotti score is associated with outcome after neoadjuvant chemotherapy for ovarian cancer.
Saner FAM; Ruggeri G; Siegenthaler F; Wampfler J; Imboden S; Mueller MD
Int J Gynecol Cancer; 2023 Oct; 33(10):1595-1601. PubMed ID: 37567597
[TBL] [Abstract][Full Text] [Related]
10. Postoperative complications in women with ovarian cancer stratified by cytoreductive surgery outcome.
Polan RM; Slota JM; Barber EL
J Surg Oncol; 2023 Oct; 128(5):891-901. PubMed ID: 37382209
[TBL] [Abstract][Full Text] [Related]
11. Development of a Novel Intra-Operative Score to Record Diseases' Anatomic Fingerprints (ANAFI Score) for the Prediction of Complete Cytoreduction in Advanced-Stage Ovarian Cancer by Using Machine Learning and Explainable Artificial Intelligence.
Laios A; Kalampokis E; Johnson R; Munot S; Thangavelu A; Hutson R; Broadhead T; Theophilou G; Nugent D; De Jong D
Cancers (Basel); 2023 Feb; 15(3):. PubMed ID: 36765924
[TBL] [Abstract][Full Text] [Related]
12. The value of PET/CT for cytoreductive surgery selection in recurrent ovarian carcinoma.
Nunes RL; Teixeira FR; Diniz TP; Faloppa CC; Mantoan H; da Costa AABA; Baiocchi G
J Gynecol Oncol; 2023 May; 34(3):e31. PubMed ID: 36731894
[TBL] [Abstract][Full Text] [Related]
13. Concordance of Radiological, Laparoscopic and Laparotomic Scoring to Predict Complete Cytoreduction in Women with Advanced Ovarian Cancer.
Di Donna MC; Cucinella G; Zaccaria G; Lo Re G; Crapanzano A; Salerno S; Giallombardo V; Sozzi G; Fagotti A; Scambia G; Laganà AS; Chiantera V
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672451
[TBL] [Abstract][Full Text] [Related]
14. Stratification of Length of Stay Prediction following Surgical Cytoreduction in Advanced High-Grade Serous Ovarian Cancer Patients Using Artificial Intelligence; the Leeds L-AI-OS Score.
Laios A; De Freitas DLD; Saalmink G; Tan YS; Johnson R; Zubayraeva A; Munot S; Hutson R; Thangavelu A; Broadhead T; Nugent D; Kalampokis E; de Lima KMG; Theophilou G; De Jong D
Curr Oncol; 2022 Nov; 29(12):9088-9104. PubMed ID: 36547125
[TBL] [Abstract][Full Text] [Related]
15. Influence of interdisciplinary frailty screening on perioperative complication rates in elderly ovarian cancer patients: results of a retrospective observational study.
Anic K; Varchola J; Schmidt MW; Schwab R; Linz VC; Schmidt M; Hardt R; Hartmann EK; Ruckes C; Hasenburg A; Battista MJ
Arch Gynecol Obstet; 2023 Jun; 307(6):1929-1940. PubMed ID: 36434440
[TBL] [Abstract][Full Text] [Related]
16. Survival and Chemosensitivity in Advanced High Grade Serous Epithelial Ovarian Cancer Patients with and without a BRCA Germline Mutation: More Evidence for Shifting the Paradigm towards Complete Surgical Cytoreduction.
De Jong D; Otify M; Chen I; Jackson D; Jayasinghe K; Nugent D; Thangavelu A; Theophilou G; Laios A
Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36363568
[TBL] [Abstract][Full Text] [Related]
17. Postoperative paralytic ileus following debulking surgery in ovarian cancer patients.
Egger EK; Merker F; Ralser DJ; Marinova M; Vilz TO; Matthaei H; Hilbert T; Mustea A
Front Surg; 2022; 9():976497. PubMed ID: 36090332
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of perioperative management of advanced ovarian (tubal/peritoneal) cancer patients: a survey from MITO-MaNGO Groups.
Greggi S; Falcone F; Aletti GD; Cascella M; Bifulco F; Colombo N; Pignata S
J Gynecol Oncol; 2022 Sep; 33(5):e60. PubMed ID: 35712972
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of a Multimodal Prehabilitation Programme in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian Cancer: A Pilot Study.
Diaz-Feijoo B; Agusti-Garcia N; Sebio R; López-Hernández A; Sisó M; Glickman A; Carreras-Dieguez N; Fuste P; Marina T; Martínez-Egea J; Aguilera L; Perdomo J; Pelaez A; López-Baamonde M; Navarro-Ripoll R; Gimeno E; Campero B; Torné A; Martinez-Palli G; Arguis MJ
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406407
[TBL] [Abstract][Full Text] [Related]
20. Predictors of postoperative pancreatic fistula after splenectomy with or without distal pancreatectomy performed as a component of cytoreductive surgery for advanced ovarian cancer.
Nishikimi K; Tate S; Matsuoka A; Otsuka S; Shozu M
J Gynecol Oncol; 2022 May; 33(3):e30. PubMed ID: 35128860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
